Tfo Tdc, LLC Biomarin Pharmaceutical Inc Transaction History

Tfo Tdc, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$76.22 - $98.51 $278,812 - $360,349	3,658 Added 912.22%	4,059 $391,000
Q3 2023 Nov 02, 2023	BUY	$85.07 - $94.48 $340 - $377	4 Added 1.01%	401 $35,000
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $34,411 - $39,819	397 New	397 $34,000
Q2 2022 Jul 18, 2022	BUY	$71.48 - $86.85 $500 - $607	7 New	7 $1,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

Stay updated on Tfo Tdc, LLC with notifications on news.